Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
The treatment of schistosomiasis, a disease caused by blood flukes parasites of the Schistosoma genus, depends on the intensive use of a single drug, praziquantel, which increases the likelihood of the development of drug-resistant parasite strains and renders the search for new drugs a strategic priority. Currently, inhibitors of human epigenetic enzymes are actively investigated as novel anti-cancer drugs and have the potential to be used as new anti-parasitic agents. Here, we report that Schistosoma mansoni histone deacetylase 8 (smHDAC8), the most expressed class I HDAC isotype in this organism, is a functional acetyl-L-lysine deacetylase that plays an important role in parasite infectivity. The crystal structure of smHDAC8 shows that this enzyme adopts a canonical α/β HDAC fold, with specific solvent exposed loops corresponding to insertions in the schistosome HDAC8 sequence. Importantly, structures of smHDAC8 in complex with generic HDAC inhibitors revealed specific structural changes in the smHDAC8 active site that cannot be accommodated by human HDACs. Using a structure-based approach, we identified several small-molecule inhibitors that build on these specificities. These molecules exhibit an inhibitory effect on smHDAC8 but show reduced affinity for human HDACs. Crucially, we show that a newly identified smHDAC8 inhibitor has the capacity to induce apoptosis and mortality in schistosomes. Taken together, our biological and structural findings define the framework for the rational design of small-molecule inhibitors specifically interfering with schistosome epigenetic mechanisms, and further support an anti-parasitic epigenome targeting strategy to treat neglected diseases caused by eukaryotic pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously shown that our smHDAC8 crystals can be used to look at inhibitor binding in a crystal latticeunbiased manner 29, 30, 55-58 .”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we previously observed a very similar binding mode to smHDAC8 for another pan-HDAC inhibitor, M344, including an interaction between D100 and the M344 internal amide group 30”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Each experiment was repeated 3–5 times and analyzed using the DDCt method [53].”
Method[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · cited 3×
“8 Å resolution was solved by molecular replacement with Phenix [57] using the hHDAC8 structure (PDB 1T69) as a search model.”
MethodInfluentialJalview Version 2—a multiple sequence alignment editor and analysis workbench
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,235
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690 · cited 1×
“Alignments were generated with JalView [61], structural panels in figures were generated with PyMOL (DeLano Scientific), and schematic interactions of the inhibitors with smHDAC8 were generated with LigPlot [62]).”
MethodJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Research works printed but not linked: 1
- KJ Prasad, 2010, Emerging and re-emerging parasitic diseases, J Int Med Sci Acad, 23, 45
Cited by
Items 101–190 of 190
Shukla, V. K., Siemons, L., Gervasio, F. L., & Hansen, D. F. (2021) · Chemical Science · doi:10.1039/d1sc01929e · Cited by 12
Saccoccia, F., Pozzetti, L., Gimmelli, R., Butini, S., Guidi, A., Papoff, G., Giannaccari, M., Brogi, S., Scognamiglio, V., Gemma, S., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102375 · Cited by 10
“The Tyr341 conformation was previously reported in its flip-in conformation in the presence of an inhibitor bound in the active site and in its flip-out conformation in the presence of tartrate (PDB entry 4bz5; (15)).”
Ja’afaru, S. C., Uzairu, A., Sallau, M. S., Ndukwe, G. I., Ibrahim, M. T., & Danazumi, A. U. (2023) · Chemistry Africa · doi:10.1007/s42250-023-00777-2 · Cited by 11
“Consequently, subsequent steps involved the assessment of Friedman LOF (LOF), the squared determination correlation coefficient of the training set (R 2 ), the adjusted square correlation coefficient ( R 2adj ), and the Cross-validation coefficient ( Q 2cv ) [30].”
InfluentialVema, A., Debnath, S., & Kalle, A. M. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103863 · Cited by 12
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages
Noce, B., Bello, E. D., Zwergel, C., Fioravanti, R., Valente, S., Rotili, D., Masotti, A., Ansari, M. S. Z., Trisciuoglio, D., Chakrabarti, A., et al. (2022) · ChemMedChem · doi:10.1002/cmdc.202200510 · Cited by 12
Self-citationVenkatesh, R., Kasaboina, S., Bidayat, D., Kumar, U. N., Jain, N., Tangeda, S. J., Bantu, R., Janardhan, S., & Nagarapu, L. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.10.071 · Cited by 11
Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity
de Menezes, R. P. B., Viana, J. D. O., Muratov, E. N., Scotti, L., & Scotti, M. T. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44010028 · Cited by 13
“org, accessed on 15 December 2021) [38]: Schistosoma mansoni 14 kDa fatty-acid-binding protein (Sm14) (transport protein, PDB ID 1VYF, ligand oleic acid) [39], histone deacetylase 8 (transferase, PDB ID 4BZ8, ligand J1038) [40], sulfotransferase (transferase, PDB ID 4MUB, ligand Oxamniquine) [41], and thioredoxin glut…”
BackgroundBinding mechanism and distant regulation of histone deacetylase 8 by PCI-34051
Luo, Y., Yan, Z., Chu, X., Zhang, Y., Qiu, Y., & Li, H. (2025) · Communications Biology · doi:10.1038/s42003-025-07649-0 · Cited by 11
Moinul, M., Amin, S. A., Khatun, S., Das, S., Jha, T., & Gayen, S. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133967 · Cited by 10
Cheuka, P. M. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210924101805 · Cited by 11
Metalloenzyme Inhibitors against Zoonotic Infections: Focus on Leishmania and Schistosoma
Rossi, S., Tudino, V., Carullo, G., Butini, S., Campiani, G., & Gemma, S. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00163 · Cited by 8
Ibrahim, H. S., Guo, M., Hilscher, S., Erdmann, F., Schmidt, M., Schutkowski, M., Sheng, C., & Sippl, W. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107887 · Cited by 8
Self-citationWang, T., Guo, X., Hong, Y., Han, H., Cao, X., Han, Y., Zhang, M., Wu, M., Fu, Z., Ke, L., et al. (2016) · Gene · doi:10.1016/j.gene.2016.07.054 · Cited by 8
Schistosomiasis: Setting Routes for Drug Discovery
Tavares, N. C., de Aguiar, P. H. N., Gava, S. G., Oliveira, G., & Mourão, M. D. M. (2016) · InTech eBooks · doi:10.5772/65386 · Cited by 10
“mansoni presents important structural differences when compared to the human orthologue, despite a single amino acid substitution in the active site [68].”
BackgroundSelf-citationAnalysis of the interactome of Schistosoma mansoni histone deacetylase 8
Caby, S., Pagliazzo, L., Lancelot, J., Saliou, J., Bertheaume, N., Pierce, R. J., & Roger, E. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006089 · Cited by 9
Self-citationFirst Barcelona Conference on Epigenetics and Cancer
Palau, A., Perucho, M., Esteller, M., & Buschbeck, M. (2014) · Epigenetics · doi:10.4161/epi.27759 · Cited by 7
“Exploiting differences in the structure of human and parasite HDACs, the Jung lab was able to generate drugs that are highly effective on SmHDAC8 but have decreased effects on key enzymes of the human host.(36) These drugs are now further optimized for potency and selectivity.”
MethodHow Has the Genomics Era Impacted Schistosomiasis Drug Discovery?
Oliveira, G., & Pierce, R. J. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.30 · Cited by 7
Self-citationde Souza, L. Â., Andrade, L. K. R., Agripino, J. D. M., da Silva, V. H. F., Emerick, S. D. O., da Silva, A. C., Pereira, L. C., Lima, G. D. D. A., Garcia, I. R., de Souza, A. C. A., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c11381 · Cited by 6
Self-citationLowe, B. D., & Fletcher, S. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130312 · Cited by 6
Du, J., Li, W., Liu, B., Zhang, Y., Yu, J., Hou, X., & Fang, H. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115607 · Cited by 6
“Consequently, HDAC8 exhibits various functions in human pathophysiology and may serves as a therapeutic target for many diseases, such as cancer[5, 6], X-linked intellectual disability[7, 8], and infections[9, 10].”
BackgroundSarkar, K., Debbarma, M., Debnath, S., Ghosh, R., & Sil, S. K. (2024) · Interactions · doi:10.1007/s10751-024-02083-w · Cited by 4
“Similar binding interactions were observed with other selective HDAC8 inhibitors [100–105] and other FDA approved HDAC inhibitors like SAHA, the control drug and pracinostat.”
Peng, Y., Gao, Q., Wang, Y., Yao, Q., & Zhang, J. (2021) · ChemMedChem · doi:10.1002/cmdc.202001004 · Cited by 4
Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni
Pagliazzo, L., Caby, S., Lancelot, J., Salomé‐Desnoulez, S., Saliou, J., Heimburg, T., Chassat, T., Cailliau, K., Sippl, W., Vicogne, J., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009503 · Cited by 4
“The analysis of the 3D structure of SmHDAC8 by X-ray crystallography [13] showed that the PLOS NEGLECTED TROPICAL DISEASES Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni”
BackgroundMethodSelf-citationRecent Advances in Anti-Schistosomiasis Drug Discovery
Marker, E. J., & Debbert, S. L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103056 · Cited by 4
Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
Yusif, M. M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100097 · Cited by 5
Gimmelli, R., Papoff, G., Saccoccia, F., Lalli, C., Gemma, S., Campiani, G., & Ruberti, G. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011992 · Cited by 4
Marek, M., Shaik, T. B., Duclaud, S., Pierce, R. J., & Romier, C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_8 · Cited by 5
Self-citationPhenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni
Hassan, M. M., Sedighi, A., Olaoye, O. O., Häberli, C., Merz, A., Ramos‐Morales, E., de Araujo, E. D., Romier, C., Jung, M., Keiser, J., et al. (2022) · ChemMedChem · doi:10.1002/cmdc.202100622 · Cited by 4
Self-citationXu, J., Wang, J.-Y., Huang, P., Liu, Z.-H., Wang, Y., Zhang, R.-Z., Ma, H., Zhou, B.-Y., Ni, X.-Y., Xiong, C., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012428 · Cited by 5
Computer-Aided Drug Design for the Identification of Novel Antischistosomal Compounds
Viana, J. D. O., Scotti, L., & Scotti, L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0635-3_2 · Cited by 3
Romanick, S., & Ferguson, B. S. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0311 · Cited by 3
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Sehr, P. A., Gunkel, N., Miller, A. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12440096.v3 · Cited by 2
Self-citationComputational design of novel therapeutics targeting Schistosomiasis, a neglected tropical disease
Ibrahim, M. T., Ja’afaru, S. C., Uzairu, A., Chandra, A., Sallau, M. S., & Singh, N. (2024) · Scientific African · doi:10.1016/j.sciaf.2024.e02326 · Cited by 2
Chowdhury, D. R., Sen, D., Roy, S. J., Majumdar, S., & Debnath, S. (2025) · ChemistrySelect · doi:10.1002/slct.202500646 · Cited by 2
Pierce, R. J., & Khalife, J. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527809257.ch16 · Cited by 2
Self-citationBanerjee, S., Baidya, S. K., Jha, T., Ghosh, B., & Adhikari, N. (2024) · Medicinal Chemistry · doi:10.2174/0115734064329669241007060848 · Cited by 1
RNA Interference and Nonspecific Controls in Parasitic Helminths
Mourão, M. D. M., & Gava, S. G. (2017) · Journal of Bacteriology & Parasitology · doi:10.4172/2155-9597.1000325 · Cited by 1
“Within the context of parasite-based research, gene function studies generate target-validation data in that RNAi-induced phenotypic changes can support drug target validation [10-13].”
BackgroundCoelho, F. S., Gava, S. G., Andrade, L. F., Geraldo, J. A., Tavares, N. C., Lunkes, F. M. N., Neves, R. H., Machado-Silva, J. R., Pierce, R. J., Oliveira, G., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1079855 · Cited by 2
“Since epigenetic proteins are promising targets for parasitic drug development, especially in helminths (Marek et al., 2013; Melesina et al., 2015) and a wide variety of epi-drugs are available; the piggy-back strategy might expedite the discovery of new specific leads and might allow the development of a new drug.”
BackgroundSelf-citationLigand-based virtual screening and QSAR modelling for the discovery of potent SmHDAC8 inhibitors
Ja’afaru, S. C., Uzairu, A., da Costa, R. A., Sallau, M. S., & Ibrahim, M. T. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100044 · Cited by 2
Structural Biology of Epigenetic Targets: Exploiting Complexity
Marek, M., Shaik, T. B., & Romier, C. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527809257.ch2 · Cited by 2
Self-citationCardoso, I. A. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2020.tde-28032020-215307 · Cited by 1
Colcerasa, A., Friedrich, F., Melesina, J., Moser, P., Vogelmann, A., Tzortzoglou, P., Neuwirt, E., Sum, M., Zhang, L., Ramos‐Morales, E., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-7x8pz-v2
Self-citationCrystallography-Based Mechanistic Insights into Epigenetic Regulation
Zhao, S., & Li, H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801080-8.00007-7
The Specificity and Regulation of Human Histone Deacetylase 8.
Pitcairn, C. A. (2015) · Deep Blue (University of Michigan)
Bassi, L. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2016.tde-20092016-094835
Marek, M., Shaik, T. B., Jung, M., Sippl, W., Pierce, R. J., & Romier, C. (2016) · Biologie Aujourd hui · doi:10.1051/jbio/2017001 · Cited by 1
Self-citationTarget Identification of HDAC8 Isoform for the Treatment of Cancer
Umamaheswari, A., Puratchikody, A., & Balasubramaniyan, S. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-7326-5.ch007
Computer‐based Lead Identification for Epigenetic Targets
Luise, C., Heimburg, T., Karaman, B., Robaa, D., & Sippl, W. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527809257.ch3
Self-citationStructure-Based Design of Epigenetic Inhibitors
Robaa, D., Melesina, J., Luise, C., & Sippl, W. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_80
Self-citationJacobs, R. T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12411-4
Nghiên cứu tương tác của vorinostat với enzyme HDAC8 (1T67) bằng Autodock
Quốc, N. C., Đệ, T. Q., Tuân, N. T., & Huê, B. T. B. (2020) · Can Tho University Journal of Science · doi:10.22144/ctu.jvn.2020.145
Identification of HDAC10 Inhibitors that Modulate Autophagy-Related Proteins in Transformed CellsPreprint
Zeyen, P., Zeyn, Y., Herp, D., Mahmoudi, F., Yesiloglu, T. Z., Erdmann, F., Schmidt, M., Robaa, D., Romier, C., Ridinger, J., et al. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-kh906
“in Strasbourg.(36) The HDAC8 activity assays were performed according to the commercial HDAC8 Fluorometric Drug Discovery Kit [Fluor de Lys(R)HDAC8, BML-KI178] corresponding to the manufacturer's instructions.”
MethodSelf-citationHerp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Sehr, P. A., Gunkel, N., Miller, A. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12440096 · Cited by 2
Self-citationColcerasa, A., Melesina, J., Moser, P., Vogelmann, A., Friedrich, F., Tzortzoglou, P., Neuwirt, E., Sum, M., Zhang, L., Ramos‐Morales, E., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-7x8pz
“25 Five isotypes of Sirtuins are expressed in Schistosoma mansoni ( Sm Sirts), and according to phylogenetic analysis they are orthologs of mammalian Sirt1, Sirt2, Sirt5, Sirt6, Sirt7.”
Self-citationFunctional characterization of long non-coding RNAs in Schistosoma mansoni
Silveira, G. O. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-07112023-145651
Ibrahim, H. S., Guo, M., Hilscher, S., Erdmann, F., Schmidt, M., Schutkowski, M., Sheng, C., & Sippl, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4821742
Self-citationRNA interference as a tool for functional genomics in parasitic helminths
Gava, S. G., & Mourão, M. D. M. (2025) · International Journal for Parasitology · doi:10.1016/j.ijpara.2025.07.002
Schistosomiasis: State of the Art and New Perspectives
Darwish, S., Teleb, M., Khattab, S. N., & Bekhit, A. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815324785125010008
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992242
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992218
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992209
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992233
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992200
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992203
Lobo-Silva, J., Cabral, F. J., Amaral, M. S., Miyasato, P. A., de Freitas, R. P., Pereira, A. S. A., Khouri, M. I., Barbosa, M. M. F., Ramos, P. I. P., Leite, L. C. C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.11992230
Imran, M., Jawaid, T., Alhuthali, H. M., Alrehaili, A. A., Alzahrani, A. R., Rehman, Z. U., Mbunge, E., & Dzinamarira, T. (2025) · Journal of Tropical Medicine · doi:10.1155/jotm/1172449 · Cited by 1
“Additionally, advancing structural information, such as crystal structures of SmHDAC8 in bound form to inhibitors, has facilitated structure-guided drug development, presenting an accessible paradigm for designing selective therapeutics [16, 25].”
InfluentialMarechal, N. (2018) · theses.fr (ABES) · doi:10.70675/a93af928zc2a8z44b2za6edz4a5650458987 · Cited by 2
Ramos‐Morales, E. (2021) · theses.fr (ABES) · doi:10.70675/c6b28473zf6b6z4024z99bfz05629f0484d7
BindingDB Entry 50018882: Inside HDACs with more selective HDAC inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q2nk3k9k
BindingDB Entry 50022755: HDAC8 as a target in drug discovery: Function, structure and design.
BindingDB (2026) · UC San Diego · doi:10.7270/q25x2frg
BindingDB (2024) · UC San Diego · doi:10.7270/q2fx7fwn
BindingDB (2020) · UC San Diego · doi:10.7270/q2jd50d0
Biochemie und Molekularbiologie 2013
(2014) · Nachrichten aus der Chemie · doi:10.1002/nadc.201490087
Metadata
- Authors
- Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., Renaud, J.-P., Oliveira, G., Sippl, W., Jung, M., Cavarelli, J., Pierce, R. J., & Romier, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Martin Luther University Halle-Wittenberg (DE)
- University of Freiburg (DE)
- Fiocruz Minas (BR)
- Corresponding author
- Pierce, Raymond J.
- Romier, Christophe
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-26
- Volume
- 9
- Issue
- 9
- Pages
- e1003645
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3784479
- OpenAlex
- W1964248507
- Cited by
- 173
- References
- 68
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 13 · 2023: 7 · 2022: 15 · 2021: 11 · 2020: 20 · 2019: 18 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 16 · 2014: 13
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- European Commission (241865)
- Agence Nationale de la Recherche (ANR-10-INBS-0005)
- European Synchrotron Radiation Facility
- Institut National de la Santé et de la Recherche Médicale
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2009-3, 573839/2008-5)
- Centre National de la Recherche Scientifique
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (PPM-00439-10)
- French Infrastructure for Integrated Structural Biology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- Schistosoma mansoni, HDAC8, HDAC8 inhibitors, epigenetic drug targets, schistosomiasis, praziquantel resistance, crystal structure, structure-based inhibitor design, small molecule inhibitors, parasite infectivity, apoptosis, neglected tropical diseases
- MeSH terms
- Animals, Histone Deacetylases, Humans, Schistosoma mansoni, Helminth Proteins, Protein Structure, Secondary, Protein Folding, Epigenesis, Genetic, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.